Cambridge, MA, United States of America

Johanna Klughammer


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Johanna Klughammer: Innovator in Molecular Spatial Mapping

Introduction

Johanna Klughammer is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of molecular spatial mapping, particularly in understanding the metastatic tumor microenvironment. Her innovative work has the potential to advance cancer research and treatment.

Latest Patents

Johanna Klughammer holds a patent for her invention titled "Molecular spatial mapping of metastatic tumor microenvironment." This patent discloses novel methods and uses for producing molecular spatial maps of metastatic breast cancer (MBC) and ductal carcinoma in situ of the breast (DCIS). The invention identifies specific genes using single-cell RNA sequencing and single-nucleus RNA sequencing, which are utilized for RNA visualization of MBC and DCIS tissue microenvironments. Her work reveals unexpected subtypes of tumor cells and provides methods for identifying molecular biomarkers for MBC in the bone and breast, as well as for DCIS. Additionally, she outlines methods for identifying therapeutic agents and their uses for treating MBC and DCIS, along with compositions comprising such identified therapeutic agents.

Career Highlights

Throughout her career, Johanna has worked with esteemed institutions such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. Her experience in these prestigious organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Johanna has collaborated with notable colleagues, including Aviv Regev and Daniel Abravanel. These partnerships have further enriched her research and innovation in the field of molecular spatial mapping.

Conclusion

Johanna Klughammer is a trailblazer in the realm of cancer research, with her innovative patent paving the way for advancements in understanding and treating metastatic breast cancer and ductal carcinoma in situ. Her contributions are invaluable to the scientific community and hold promise for future breakthroughs in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…